PASTEURELLA MULTOCIDA TOXIN--STRUCTURE AND ACTIVITY
多杀性巴氏杆菌毒素——结构和活性
基本信息
- 批准号:6169281
- 负责人:
- 金额:$ 10.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:3T3 cells G protein Pasteurella multocida SDS polyacrylamide gel electrophoresis Xenopus oocyte bacterial proteins bacterial toxicology bacterial toxins biological signal transduction covalent bond gene deletion mutation microinjections polymerase chain reaction protein sequence protein structure function receptor binding receptor coupling recombinant proteins transfection western blottings
项目摘要
Pasteurella multocida is a pathogenic bacterium associated with the
agricultural diseases pasteurellosis, hemorrhagic septicemia,
dermonecrosis, and progressive atrophic rhinitis. P. multocida can cause
severe complications in human infections from animal bites or scratches,
respiratory infections, and exposure to animals during pregnancy. P.
multocida toxin is an important virulence factor of P. multocida, and
purified PMT alone is sufficient to experimentally induce progressive
atrophic rhinitis. PMT appears to enter cells via receptor-mediated
endocytosis and causes activation of signal transduction events and DNA
synthesis. Recent studies from our laboratory have identified G alpha
protein as the primary target of PMT action that activates the
phosphatidylinositol-specific phospholipase C-beta 1 and the inositol
triphosphate pathway in Xenopus oocytes. Studies from our laboratory have
also shown that the N-terminus of PMT is important for this activity, and
we have proposed a model for PMT's intracellular action. We have cloned
the entire toxA gene (1285 residues) from P. multocida and have generated
a number of deletion mutants, encoding residues 1-73, 1-293, 1-506, 506-
1285, and 1059-1285. Our long range goals are to use these recombinant
proteins to understand the structure and mechanism of action of PMT at
the molecular and biochemical level, both to facilitate future
therapeutic intervention in the bacterial pathogenesis of P. multocida
, as well as to provide insight into the molecular signalling events
involved in the control of cell growth and differentiation. In
particular, we hope to demonstrate the utility of PMT as a new
biochemical tool for studying intracellular signalling pathways involving
the Gq family of regulatory proteins. To achieve our goals, we propose
the following:
(1) To define the functional domains of the protein, so as to determine
which of the toxin's domains are responsible for (1) binding to the
eukaryotic cell receptors and (2) stimulating the intracellular signal
transduction pathways.
(2) To elucidate the molecular mechanism by which PMT activates Gq-
protein, by determining whether PMT's activation of Gq-protein is caused
by a covalent modification or by noncovalent interaction.
(3) To test the hypothesis that PMT uncouples the ligand-regulated
interaction between receptor and Gq-protein, using the Xenopus oocyte
system overexpressing exogenous 5-HT2 receptor and Gqalpha-protein.
多杀性巴氏杆菌是一种致病细菌,与
农业疾病巴氏杆菌病,出血性败血症,
皮肤病和进行性萎缩性鼻炎。多杀性巴氏杆菌可引起
动物咬伤或抓伤引起的人类感染的严重并发症,
呼吸道感染,以及在怀孕期间接触动物。P.
多杀性毒素是多杀性巴氏杆菌重要的毒力因子。
仅纯化的PMT就足以在实验中诱导进展
萎缩性鼻炎。PMT似乎通过受体介导进入细胞
内吞作用与信号转导事件和DNA的激活
综合。我们实验室最近的研究已经确定了Gα
蛋白质作为PMT作用的主要靶点,激活
磷脂酰肌醇特异性磷脂酶C-β1和肌醇
非洲爪哇卵母细胞中的三磷酸途径。我们实验室的研究表明
还表明PMT的N末端对这一活动很重要,以及
我们提出了PMT细胞内作用的模型。我们已经克隆了
多杀性巴氏杆菌的整个ToxA基因(1285个残基)已经产生了
一些缺失突变体,编码残基1-73、1-293、1-506、506-
1285和1059-1285。我们的长期目标是利用这些重组
了解PMT的结构和作用机制的蛋白质
分子和生化层面,都是为了促进未来
多杀性巴氏杆菌致病机制的治疗干预
,以及提供对分子信号事件的洞察
参与控制细胞的生长和分化。在……里面
特别是,我们希望展示PMT作为一种新的
用于研究细胞内信号通路的生化工具
GQ调节蛋白家族。为了实现我们的目标,我们建议
以下内容:
(1)确定蛋白质的功能结构域,以确定
毒素的哪个结构域负责(1)与
真核细胞受体和(2)刺激细胞内信号
转导通路。
(2)阐明PMT激活GQ的分子机制。
蛋白质,通过确定PMT对Gq蛋白的激活是否导致
通过共价修饰或通过非共价相互作用。
(3)检验PMT解偶联配体调控的假设
利用非洲爪哇卵母细胞研究受体与Gq蛋白的相互作用
系统过度表达外源性5-HT2受体和GqAlpha蛋白。
项目成果
期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.
多杀性巴斯德氏菌毒素对有丝分裂信号传导和细胞周期进程进行差异调节和随后的阻断。
- DOI:10.1128/iai.68.8.4531-4538.2000
- 发表时间:2000
- 期刊:
- 影响因子:3.1
- 作者:Wilson,BA;Aminova,LR;Ponferrada,VG;Ho,M
- 通讯作者:Ho,M
Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility.
Galpha(q) 激动剂多杀性巴斯德氏菌毒素具有促进心肌细胞肥大和增强细胞凋亡易感性的双重作用。
- DOI:10.1161/01.res.0000016165.23795.1f
- 发表时间:2002
- 期刊:
- 影响因子:20.1
- 作者:Sabri,Abdelkarim;Wilson,BrendaA;Steinberg,SusanF
- 通讯作者:Steinberg,SusanF
Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1.
多杀性巴氏杆菌毒素通过 G(q)α 偶联磷脂酶 C-β1 激活非洲爪蟾卵母细胞中的肌醇三磷酸信号通路。
- DOI:10.1074/jbc.272.2.1268
- 发表时间:1997
- 期刊:
- 影响因子:0
- 作者:Wilson,BA;Zhu,X;Ho,M;Lu,L
- 通讯作者:Lu,L
Rho/ROCK-dependent inhibition of 3T3-L1 adipogenesis by G-protein-deamidating dermonecrotic toxins: differential regulation of Notch1, Pref1/Dlk1, and β-catenin signaling.
- DOI:10.3389/fcimb.2012.00080
- 发表时间:2012
- 期刊:
- 影响因子:5.7
- 作者:Bannai Y;Aminova LR;Faulkner MJ;Ho M;Wilson BA
- 通讯作者:Wilson BA
Backbone and side-chain resonance assignments of the membrane localization domain from Pasteurella multocida toxin.
- DOI:10.1007/s12104-013-9487-1
- 发表时间:2014-04
- 期刊:
- 影响因子:0.9
- 作者:Brothers MC;Geissler B;Hisao GS;Satchell KJ;Wilson BA;Rienstra CM
- 通讯作者:Rienstra CM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brenda A. Wilson其他文献
Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
白喉毒素和铜绿假单胞菌外毒素 A:活性位点结构和酶机制。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:0
- 作者:
Brenda A. Wilson;R. Collier - 通讯作者:
R. Collier
Effect of Antibiotic Treatment on the Gastrointestinal Microbiome of Free-Ranging Western Lowland Gorillas (Gorilla g. gorilla)
- DOI:
10.1007/s00248-016-0745-5 - 发表时间:
2016-03-16 - 期刊:
- 影响因子:4.000
- 作者:
Klára Vlčková;Andres Gomez;Klára J. Petrželková;Christopher A. Whittier;Angelique F. Todd;Carl J. Yeoman;Karen E. Nelson;Brenda A. Wilson;Rebecca M. Stumpf;David Modrý;Bryan A. White;Steven R. Leigh - 通讯作者:
Steven R. Leigh
Brenda A. Wilson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brenda A. Wilson', 18)}}的其他基金
Neuronal-specific cargo-delivery platforms as post-exposure botulism therapies
作为暴露后肉毒杆菌疗法的神经元特异性货物递送平台
- 批准号:
8851508 - 财政年份:2012
- 资助金额:
$ 10.53万 - 项目类别:
Neuronal-specific cargo-delivery platforms as post-exposure botulism therapies
作为暴露后肉毒杆菌疗法的神经元特异性货物递送平台
- 批准号:
8471649 - 财政年份:2012
- 资助金额:
$ 10.53万 - 项目类别:
Neuronal-specific cargo-delivery platforms as post-exposure botulism therapies
作为暴露后肉毒杆菌疗法的神经元特异性货物递送平台
- 批准号:
8367174 - 财政年份:2012
- 资助金额:
$ 10.53万 - 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
- 批准号:
7457963 - 财政年份:2007
- 资助金额:
$ 10.53万 - 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
- 批准号:
7918949 - 财政年份:2007
- 资助金额:
$ 10.53万 - 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
- 批准号:
7640765 - 财政年份:2007
- 资助金额:
$ 10.53万 - 项目类别:
Targeted antitoxin delivery platforms as post-exposure therapies for botulism
靶向抗毒素递送平台作为肉毒杆菌中毒的暴露后疗法
- 批准号:
7325538 - 财政年份:2007
- 资助金额:
$ 10.53万 - 项目类别:
Pasteurella multocida toxin: Structure and Activity
多杀性巴氏杆菌毒素:结构和活性
- 批准号:
7189132 - 财政年份:1996
- 资助金额:
$ 10.53万 - 项目类别:
Pasteurella multocida toxin: Structure and Activity
多杀性巴氏杆菌毒素:结构和活性
- 批准号:
7024490 - 财政年份:1996
- 资助金额:
$ 10.53万 - 项目类别:
PASTEURELLA MULTOCIDA TOXIN--STRUCTURE AND ACTIVITY
多杀性巴氏杆菌毒素——结构和活性
- 批准号:
2457834 - 财政年份:1996
- 资助金额:
$ 10.53万 - 项目类别:
相似海外基金
Intelligent cryo-electron microscopy of G protein-coupled receptors
G 蛋白偶联受体的智能冷冻电子显微镜
- 批准号:
23K23818 - 财政年份:2024
- 资助金额:
$ 10.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cryo-electron microscopy determination of G protein-coupled receptor states
冷冻电镜测定 G 蛋白偶联受体状态
- 批准号:
DE230101681 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Discovery Early Career Researcher Award
Development of multidrug combination molecular targeted therapeutics based on G protein-coupled receptor interactions in glioblastoma
基于G蛋白偶联受体相互作用的胶质母细胞瘤多药组合分子靶向治疗的开发
- 批准号:
23K08551 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
RUI: Identifying reproductive roles for the Super-conserved Receptors Expressed in Brain (SREB) G protein-coupled receptor family using novel agonists and a comparative fish model
RUI:使用新型激动剂和比较鱼类模型确定脑中表达的超级保守受体 (SREB) G 蛋白偶联受体家族的生殖作用
- 批准号:
2307614 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Continuing Grant
The Role of Intermediate Conformations in G Protein-coupled Receptor Signaling
中间构象在 G 蛋白偶联受体信号传导中的作用
- 批准号:
10635763 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
India Link: Selective interactions between G protein-coupled receptors and conformationally selective arrestin variants
India Link:G 蛋白偶联受体与构象选择性抑制蛋白变体之间的选择性相互作用
- 批准号:
BB/T018720/1 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Research Grant
Architecture of inhibitory G protein signaling in the hippocampus
海马抑制性 G 蛋白信号传导的结构
- 批准号:
10659438 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Molecular mechanisms of GPCR/G protein diseases and drug development
GPCR/G蛋白疾病的分子机制及药物开发
- 批准号:
23K07998 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research Initiation Award: Exploring Class A G-Protein Coupled Receptors (GPCRs)-Ligand Interaction through Machine Learning Approaches
研究启动奖:通过机器学习方法探索 A 类 G 蛋白偶联受体 (GPCR)-配体相互作用
- 批准号:
2300475 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Standard Grant
Structure and dynamics of class B1 G protein coupled receptors
B1类G蛋白偶联受体的结构和动力学
- 批准号:
DP230102776 - 财政年份:2023
- 资助金额:
$ 10.53万 - 项目类别:
Discovery Projects